How does SARS-CoV-2 infection lead to future neurodegeneration as a long-term consequence?

OPEN

The authors mention COVID-19 plays a crucial role in developing future neurological diseases as long-term consequences, but the pathophysiological mechanisms are unexplained. This gap is critical for understanding post-COVID neurological sequelae and developing preventive strategies. Gap type: unexplained_observation Source paper: COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? (2021, Journal of neurology, PMID:32696341)

Priority: 0.82 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: How does SARS-CoV-2 infection lead to future neurodegeneration as a long-term consequence? is a 0.82 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How does SARS-CoV-2 infection lead to future neurodegeneration as a long-term consequence? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (1)

TMPRSS2SARS-CoV-2

associated with (3)

SARS-CoV-2Bone Marrow Plasma CellsTMPRSS2SARS-CoV-2FCGRTSARS-CoV-2

binds (1)

ACE2SARS-CoV-2

causes (3)

SARS-CoV-2Microglia DysfunctionSARS-CoV-2Neurological SequelaeSARS-CoV-2Bone Marrow Plasma Cells

demonstrates infectivity in (1)

36001241SARS-CoV-2

detected in (1)

36001241SARS-CoV-2

exploits (1)

38247815SARS-CoV-2

inhibits (2)

Anti-receptor binding domain antibodiesSARS-CoV-2SARS-CoV-2Antiviral Innate Immunity

interacts with (1)

FCGRTSARS-CoV-2

is associated with (1)

36626425SARS-CoV-2

modulates (1)

SARS-CoV-2UBIQUITIN

persists in (1)

36001241SARS-CoV-2

produces (1)

38247815SARS-CoV-2

protects against (2)

Anti-Receptor Binding Domain AntibodiesSARS-CoV-2Anti-receptor Binding Domain AntibodiesSARS-CoV-2

remains (1)

36001241SARS-CoV-2
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps